Webinar: Streamlining the CAR-T Development Pathway in the EU
March 2025
The aim of our Join4ATMP webinars will be to showcase the challenges in the ATMP development pathway, from pre-clinical research, GMP manufacturing through to clinical translation, market approval, price reimbursement and ultimately patient access.
Patient involvement in the ATMP development is critical to ensure the identification of meaning outcomes and endpoints that can demonstrate clinical efficiency, patient safety and therapeutic value.
These webinars will start the engagement with patient community and warm up the discussion on the hurdles of the existing ATMP development pathway, specifically to:
- Identify the existing changes and hurdles for ATMP research and development pathway.
- Chart the solutions to speed up and make leaner the development pathway to cultivating a viable and healthy pipeline of new ATMPs.
- Explore the opportunity of JOIN4ATMP to identify the key huddles and barriers and co-design the recommendations that can strengthen the ATMP eco-system in Europe.
The webinars will explain the transformative nature of CAR-T treatment using a haematology example as well as how patient safety and efficacy of these innovative treatments is being improved. The challenges to translate a promising asset from pre-clinical through GMP manufacturing and clinical trial pathway, to regulator approval will be showcased in three presentations
The session will be chaired by Matt Bolz-Johnson, ATMP & Mental Health Advisor, EURORDIS.
Panelists at the webinar will include:
- Antonia Mueller, Medical University Wien.
- Reno Debets, Erasmus University Medical Center.
- Silva Martin Lluesma, Vall d’Hebron Institute of Oncology & CEU San Pablo University.
- Natacha Boplaños, Lymphoma Coalition.
The first webinar of this series will took place on 10 April, focusing on the topic of Streamlining the ATMP Development Pathway in the EU.
💬 Webinar Two: Streamlining the CAR-T Development Pathway in the EU
➡️ Register now!
🗓️ 12 May 2025
⏰ 14.00-15.30 CET